ClinicalTrials.Veeva

Menu

Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Multicenter Cohort Study) III

N

Nanjing Medical University

Status

Completed

Conditions

Aortic Dissection

Treatments

Biological: inflammatory response

Study type

Observational

Funder types

Other

Identifiers

NCT04918108
5A Plan

Details and patient eligibility

About

Anatomopathological classifications have been well identified in aortic dissection with important therapeutic implications. The authors evaluated the inflammatory response in patients with aortic dissection (AD) and assessed the presence of distinct inflammatory subphenotypes within this disease.

Enrollment

2,000 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute type Aortic dissection;

Exclusion criteria

  • Iatrogenic aortic dissection OR traumatic aortic dissection
  • Patients with hematological diseases, infectious diseases, malignant tumors, immune system diseases, or severe liver diseases.
  • Preoperative use of mechanical ventilation, blood transfusion, renal replacement therapy, extracorporeal membrane oxygenation, or intra-aortic balloon pump during the current admission.

Trial design

2,000 participants in 1 patient group

inflammatory subphenotype
Treatment:
Biological: inflammatory response

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems